Supply control

The Effects of COVID-19 on the Illegal Drug Supply

Created by
CCSA

 

This webinar explored how regulations put in place to prevent the spread of COVID-19 are inadvertently contributing to an increasingly toxic illegal drug supply and how this shift has both increased health harms and created policy opportunities. Presentations highlighted different perspectives, including systems-level epidemiology data, findings from a local drug checking program and experiences shared by people who use drugs.

The Effects of COVID-19 on the Illegal Drug Supply

Webinar,

This webinar will explore how regulations put in place to prevent the spread of COVID-19 are inadvertently contributing to an increasingly toxic illegal drug supply and how this shift has both increased health harms and created policy opportunities. Presentations will highlight different perspectives, including systems-level epidemiology data, findings from a local drug checking program and experiences shared by people who use drugs.

The Rapidly Changing Composition of the World's Drug Supply and Its Effects on High-Risk for COVID-19

Arizona, United States,
The second of two presentations by Thom Browne Jr. (MA Criminal Justice, CEO of Colombo Plan) on the emerging and rapidly-changing properties of illicit drugs and their cutting agents that put substance users worldwide at high-risk for near- and long-term chronic health problems, overdose (fatal & non-fatal), and increased vulnerability to both the acquisition of viruses like COVID-19 and more severe complications from the virus.

The Rapidly Changing Composition of the World's Drug Supply and Its Effects on High-Risk for COVID-19

Arizona, United States,
The first of two presentations by Thom Browne Jr. (MA Criminal Justice, CEO of Colombo Plan) on the emerging and rapidly-changing properties of illicit drugs and their cutting agents that put substance users worldwide at high-risk for near- and long-term chronic health problems, overdose (fatal & non-fatal), and increased vulnerability to both the acquisition of viruses like COVID-19 and more severe complications from the virus.